Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia

Published:2010-09-30 Issue:22 Volume:16 Page:5424-5435
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Chapuis Nicolas,Tamburini Jerome,Green Alexa S.,Vignon Christine,Bardet Valerie,Neyret Aymeric,Pannetier Melanie,Willems Lise,Park Sophie,Macone Alexandre,Maira Sauveur-Michel,Ifrah Norbert,Dreyfus François,Herault Olivier,Lacombe Catherine,Mayeux Patrick,Bouscary Didier

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications;Journal of Medicinal Chemistry;2024-04-02

2. XBP1 promotes NRAS^G12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS;Journal of Cellular and Molecular Medicine;2023-09-27

3. The effects of MYC on tumor immunity and immunotherapy;Cell Death Discovery;2023-03-25

4. MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice;International Journal of Molecular Sciences;2023-03-23

5. A pyridinesulfonamide derivative FD268 suppresses cell proliferation and induces apoptosis via inhibiting PI3K pathway in acute myeloid leukemia;PLOS ONE;2022-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP